Hope E Baylow1, Mitra Esfandiarei2, Ileana Ratiu3,4. 1. Department of Health and Human Performance, The University of Scranton, Edward Leahy Hall Rm. 824, 800 Linden St, Scranton, PA, 18510, USA. hope.baylow@scranton.edu. 2. Department of Biomedical Sciences, Midwestern University, Glendale, AZ, USA. 3. Department of Speech and Hearing Science, Arizona State University, Tempe, AZ, USA. 4. Speech-Language Pathology Program, Midwestern University, Glendale, AZ, USA.
Abstract
PURPOSE: Marfan syndrome (MFS) is a connective tissue disorder that affects skeletal, ocular, pulmonary, cardiovascular, and central nervous systems. Symptoms may lead to diminished quality of life (QoL) in individuals with MFS compared with healthy individuals. Currently, there is little evidence regarding the impact of MFS on swallowing and QoL. This study examined perceptions of swallowing difficulties and QoL among persons with MFS. METHOD: A total of 356 participants (1% response rate) with a self-reported diagnosis of MFS provided medication regime and completed a Quality-of-Life Index and a modified version of the SWAL-QOL used to assess 8 QOL concepts related to swallowing: burden, duration, desire, food choice, fear, mental health, social concerns, and fatigue. RESULTS: Dysphagia symptoms were reported by 62% (N = 356) of the participants. Analyses assessing correlations between responses to SWAL-QOL questions, QoL scores, and reported medications were conducted. Further, responses on the SWAL-QOL predicted QoL satisfaction, even after controlling for medications. Findings revealed that greater swallowing difficulty affects QoL satisfaction and overall QoL, but not QoL importance. Further, specific medications were associated with differences in swallowing difficulty as well as QoL satisfaction. CONCLUSIONS: The findings of the current study suggest that individuals with MFS may experience specific swallowing difficulties which impact QoL. Specific classes of drugs may also be associated with reported swallowing QoL and QoL satisfaction in MFS. These findings have implications for clinicians who work with individuals with MFS.
PURPOSE: Marfan syndrome (MFS) is a connective tissue disorder that affects skeletal, ocular, pulmonary, cardiovascular, and central nervous systems. Symptoms may lead to diminished quality of life (QoL) in individuals with MFS compared with healthy individuals. Currently, there is little evidence regarding the impact of MFS on swallowing and QoL. This study examined perceptions of swallowing difficulties and QoL among persons with MFS. METHOD: A total of 356 participants (1% response rate) with a self-reported diagnosis of MFS provided medication regime and completed a Quality-of-Life Index and a modified version of the SWAL-QOL used to assess 8 QOL concepts related to swallowing: burden, duration, desire, food choice, fear, mental health, social concerns, and fatigue. RESULTS: Dysphagia symptoms were reported by 62% (N = 356) of the participants. Analyses assessing correlations between responses to SWAL-QOL questions, QoL scores, and reported medications were conducted. Further, responses on the SWAL-QOL predicted QoL satisfaction, even after controlling for medications. Findings revealed that greater swallowing difficulty affects QoL satisfaction and overall QoL, but not QoL importance. Further, specific medications were associated with differences in swallowing difficulty as well as QoL satisfaction. CONCLUSIONS: The findings of the current study suggest that individuals with MFS may experience specific swallowing difficulties which impact QoL. Specific classes of drugs may also be associated with reported swallowing QoL and QoL satisfaction in MFS. These findings have implications for clinicians who work with individuals with MFS.
Authors: Grant T Fankhauser; William M Stone; Richard J Fowl; Mark E O'Donnell; Thomas C Bower; Fredric B Meyer; Samuel R Money Journal: J Vasc Surg Date: 2014-08-21 Impact factor: 4.268
Authors: Judith Z Goldfinger; Liliana R Preiss; Richard B Devereux; Mary J Roman; Tabitha P Hendershot; Barbara L Kroner; Kim A Eagle Journal: J Am Coll Cardiol Date: 2017-06-13 Impact factor: 24.094
Authors: Christopher A Behr; Naomi-Liza Denning; Michelle P Kallis; Caroline Maloney; Samuel Z Soffer; Angela Romano-Adesman; Andrew R Hong Journal: J Pediatr Surg Date: 2018-12-27 Impact factor: 2.545